DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
H•••••• C••• S•••••••• P•• L••
Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Jun 30, 2024sponsor unattributed
Nothing material in the last 200 days. Last change: 30 Jun 2024, Consensus mark 87¢ on cost, up from 83¢ a year ago, 85¢ last quarter.
Mark path, consensus per quarter end
83¢ · 81¢ · 89¢ · 85¢ · 87¢Q2 2023 to Q2 2024
Principal held
at least $367,000
sum of BDC pieces, a lower bound
Fair value
$367,000
87c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2024
Events
3
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2024, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| B•••••• P•••••• C••••• C••• | $367K | 87¢ | +2 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B•••••• P•••••• C••••• C••• | term loan first lien F•••• L••• S••••• S•••••• T••• L••• | $367,000 | $367,000 87c | S+500 bp |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2024
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Jun 30, 2024 | at least $367,000 | 87c | S+500 bp | unstated | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2024 | 1 | $367,000 | $367,000 | 87c | 0 |
| Mar 31, 2024 | 1 | $363,000 | $363,000 | 85c | 0 |
| Dec 31, 2023 | 1 | $380,000 | $379,000 | 89c | 0 |
| Sep 30, 2023 | 1 | $925,000 | $886,000 | 81c | 0 |
All 7 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2023 | 1 | $954,000 | $911,000 | 83c | 0 |
| Mar 31, 2023 | 1 | $973,000 | $939,000 | 85c | 0 |
| Dec 31, 2022 | 1 | $2.0M | $2.0M | 87c | 0 |
What changed
- Facility left every BDC scheduleJun 30, 2024
- Mark recoveredDec 31, 2023
- New borrower on a BDC scheduleDec 31, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- H•••••• C••• S••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it